Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 7, No 1 (2011) NEW ANTIPLATELET DRUGS (PART 1) Abstract  similar documents
A. B. Sumarokov
"... Antiplatelet agents are a necessary component of modern atherosclerosis therapy. The difficulties ..."
 
Vol 8, No 1 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... , renalase, endothelin receptors, (pro)renin receptors, vaccine against RAAS components. Development of novel ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... , renalase, endothelin receptors, (pro)renin receptors, vaccine against RAAS components. Development of novel ..."
 
Vol 7, No 5 (2011) NEW ANTIPLATELET DRUGS. PART 2 Abstract  similar documents
A. B. Sumarokov
"... Antiplatelet agents are a necessary component of modern therapy of atherosclerosis ..."
 
Vol 11, No 2 (2015) A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE Abstract  similar documents
B. B. Gegenava, O. M. Drapkina
"... of the selective antagonist of mineralocorticoid receptor eplerenone are analyzed. The advantages of eplerenone ..."
 
Vol 9, No 2 (2013) PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET Abstract  similar documents
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova
"... initially and during treatment. Doses of antihypertensive and erythropoiesis-stimulating agents were also ..."
 
Vol 8, No 2 (2012) TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... Data on angiotensin II receptor blockers, one of the main drug classes used in cardiology ..."
 
Vol 14, No 4 (2018) Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome Abstract  similar documents
O. M. Drapkina, O. E. Shirobokikh
"... modulate host lipid metabolism as well as carbohydrate metabolism through several receptors such as G ..."
 
Vol 10, No 6 (2014) IRBESARTAN IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first ..."
 
Vol 9, No 6 (2013) POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK Abstract  similar documents
Z M. Sizova
"... Current possibilities of AT1 receptor blockers (ARBs), such as candesartan, for optimization ..."
 
Vol 4, No 5 (2008) INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS Abstract  similar documents
V. V. Fomin
"... and cardiovascular complications are discussed with focus on usage of angiotensin II receptor blockers. ..."
 
Vol 11, No 6 (2015) Cardiometabolic properties of telmisartan: new perspectives for use Abstract  similar documents
O. M. Drapkina, E. I. Fomicheva
"... -альдостероновую систему (РААС) через блокаду АТ1-рецепторов, второе поколение АРА II – это бифункциональные ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... + diet), group A2 (ACE inhibitor + fluvastatin), group B1 (angiotensin II receptor antagonist (ARA II ..."
 
Vol 5, No 4 (2009) TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS Abstract  similar documents
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
"... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..."
 
Vol 6, No 5 (2010) THE POLYMORPHISM OF Α2B-ADRENERGIC RECEPTOR GENE — A NEW GENETIC MARKER OF THE HEREDITARY SICK SINUS SYNDROME Abstract  similar documents
S. Iu. Nikulina, V. A. Shulman, A. A. Chernova, D. A. Nikulin, M. I. Voevoda, V. N. Maksimov
"... receptor (ADRA2B) polymorphism. Material and methods. 29 families with hereditary primary SSS from ..."
 
Vol 6, No 1 (2010) ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya
"... receptor antagonist (ARA), valsartan at the cardiovascular continuum (CVC) stages. Material and methods ..."
 
Vol 12, No 3 (2016) MEMBRANE BILE ACID RECEPTOR TGR5 - A NEW TARGET IN THE STUDY OF METABOLIC, INFLAMMATORY AND NEOPLASTIC DISEASES Abstract  PDF (Eng)  similar documents
O. M. Drapkina, E. I. Fomicheva
"... TGR5 are G-protein-linked, membrane bile acids receptors that widely express in tissues of animals ..."
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... important mechanisms for the realization of the cardiovascular continuum. The role that angiotensin receptor ..."
 
Vol 13, No 4 (2017) PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY Abstract  similar documents
O. M. Drapkina, D. U. Akasheva
"... with reduced ejection fraction (<40%). Antagonists of mineralocorticoid receptors, along with angiotensin ..."
 
Vol 2, No 2 (2006) METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS Abstract  similar documents
N. V. Perova, I. N. Ozerova, V. A. Metelskaya
"... , скавенджер-рецептор, аторвастатин. РФК 2006; 2: 49-56 Metabolic system of cholesterol elimination from ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... Aim. To study the doctors' opinions on the main aspects of antiplatelet agents use, and to test ..."
 
Vol 10, No 6 (2014) PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION Abstract  similar documents
N. V. Mikheeva, O. V. Reshetko, N. V. Furman
"... рецепторов ангиотензина II (БРА II), диуре- тик (индапамид), статины – группы ЛС, обладающие доказанной ..."
 
Vol 8, No 2 (2012) IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? Abstract  similar documents
D. V. Nebieridze, T. V. Kamyshova
"... The role of selective I1 imidazoline receptor agonists and moxonidine in particular , in modern ..."
 
Vol 8, No 2 (2012) RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS Abstract  similar documents
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova
"... — ингибиторов ци- клооксигеназы (ацетилсалициловая кислота — АСК) и ингибиторы АДФ рецепторов (клопидогрел ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... Y12-receptor blockers. Ration Pharmacother Cardiol 2015;11(4):344-354 Влияние метаболической ..."
 
Vol 4, No 4 (2008) PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY Abstract  similar documents
S. A. Boytsov, I. P. Kolos
"... Angiotensin II receptor antagonists (ARA) established their position recently duet to new ..."
 
Vol 9, No 6 (2013) SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS Abstract  similar documents
S. R. Gilyarevskiy
"... ингибитором ангиотензинпре- вращающего фермента (АПФ), блокатором рецепторов ангиотензина II, или антагонистом ..."
 
Vol 9, No 4 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT Abstract  similar documents
S. Yu. Martsevich
"... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..."
 
Vol 7, No 4 (2011) SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION Abstract  similar documents
S. V. Nedogoda
"... Peculiarities of the treatment with angiotensin II receptor blocker telmisartan are analyzed ..."
 
Vol 9, No 6 (2013) THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY Abstract  similar documents
A. V. Shulkin, E. N. Yakusheva, N. M. Popova
"... agents and anticoagulants. Determination of C3435T polymorphism of multidrug resistance gene (MDR1 ..."
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... and Angiotensin Receptor Blockers in Patients Without Heart Failure» J Am Coll Cardiol 2013;61(2):131-42;   http ..."
 
Vol 11, No 3 (2015) ALCOHOL AND HEART RHYTHM DISORDERS Abstract  similar documents
A. O. Yusupova, A. S. Lishuta
"... сродством к μ-, δ- и κ-рецепторам. Налмефен является блокатором в отношении μ- и δ- рецепторов и ча- стичным ..."
 
Vol 9, No 2 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY Abstract  similar documents
S. Yu. Martsevich
"... -Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure ..."
 
Vol 3, No 2 (2007) CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS Abstract  similar documents
V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina
"... and peripheral hemodynamics and to evaluate how these characteristics are influenced by angiotensin II receptors ..."
 
Vol 6, No 2 (2010) NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER Abstract  similar documents
T. Műnzel, T. Gori
"... . Nebivolol. The somewhat-different β-adrenergic receptor blocker was initially published in J Am Coll Cardiol ..."
 
Vol 12, No 3 (2016) GENETIC PREDICTORS OF ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina
"... and angiotensin II receptor antagonists in the prevention of AF is revealed. RAAS blockers are able not only ..."
 
Vol 5, No 3 (2009) FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY Abstract  similar documents
O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova
"... (иАПФ) и антагонистов рецепторов ангиотензина II (АРА II) на эти механизмы. В литературе недостаточно ..."
 
Vol 8, No 5 (2012) TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE Abstract  similar documents
M. M. Rogova, N. A. Mironova, E. S. Rodionova, T. A. Malkina, K. A. Zykov, Zh. D. Bespalova, R. Sh. Bibilashvili, E. E. Efremov, S. P. Golitsyn
"... -cholinergic receptors, and to evaluate their possible contribution to the development and maintenance ..."
 
Vol 4, No 1 (2008) EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY Abstract  similar documents
S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza
"... Aim. To compare the effects of long-term therapy with angiotensin-II receptor antagonist losartan ..."
 
Vol 9, No 1 (2013) POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
"... of glycoprotein (GP) IIb/IIIa receptor level and the expression of P-selectin before and after ADP induction ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... : selective thromboxane inhibitors, antagonists of thromboxane receptors, blockers of platelet receptors ..."
 
Vol 13, No 1 (2017) VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE Abstract  similar documents
V. А. Korneva, T. Yu. Kuznetsova, G. P. Tihova
"... was performed in 102 patients (46.6%); pathogenic mutation in the LDL receptor was identified in 21 patients ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
"... тромбоцитов — антагонисты рецептора P2Y12, тиенопиридины. Эта группа представлена не- сколькими препаратами ..."
 
Vol 7, No 4 (2011) COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) Abstract  similar documents
O. V. Dralova, M. L. Maksimov
"... терапии могут использоваться α-ад- реноблокаторы, агонисты имидазолиновых рецепторов и прямой ингибитор ..."
 
Vol 14, No 6 (2018) P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva
"... The possibilities of P2Y12 receptor inhibitors application in the treatment of patients with acute ..."
 
Vol 15, No 3 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State Abstract  similar documents
I. A. Skripnikova, O. V. Kosmatova, M. A. Kolchinа, M. A. Myagkova, N. A. Alikhanova
"... antiresorptive drugs (bisphosphonates, monoclonal antibodies to RANKL, selective estrogen receptor modulators ..."
 
Vol 7, No 4 (2011) EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. I. Makhiyanova, A. S. Galyavich
"...   Цель. Изучить эффективность и безопасность блокатора гликопротеиновых рецепторов IIb/IIIа ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) and β-blockers in the outpatient ..."
 
Vol 10, No 3 (2014) NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS Abstract  similar documents
O. M. Drapkina, L. O. Palatkina
"... reduction in patients with CHF with preserved ejection fraction using well-known therapeutic agents ..."
 
Vol 13, No 4 (2017) PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW Abstract  similar documents
I. S. Yavelov
"... and safety of prolonged use of a combination of acetylsalicylic acid and blocker P2Y12 platelet receptor ..."
 
Vol 10, No 5 (2014) CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE Abstract  similar documents
S. V. Gatsura, O. A. Gatsura, A. N. Golosova
"... regarding initial antihypertensive agents for therapy of uncomplicated mild to moderate HT taking ..."
 
Vol 12, No 1 (2016) Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension) Abstract  PDF (Eng)  similar documents
E. L. Trisvetova, S. V. Gubkin
"... , specific therapy with calcium channel blockers, prostacyclin analogues, endothelin receptor antagonists ..."
 
Vol 13, No 6 (2017) THIOL ISOMERASES – A POSSIBLE TARGET FOR THROMBOSIS CONTROL Abstract  similar documents
I. V. Gribkova, M. V. Davydovskaya
"... While there are an increasing number of antithrombotic agents with demonstrated clinical efficacy ..."
 
Vol 2, No 4 (2006) FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS Abstract  similar documents
Yu. M. Lopatin
"... inhibitor and antagonist of angiotensin II receptor are discussed. ..."
 
Vol 6, No 4 (2010) CLOPIDOGREL PHARMACOGENETICS Abstract  similar documents
A. N. Meshkov
"... agents all over the world is clopidogrel, R2Y12-receptor blocker. It is shown that clopidogrel has ..."
 
Vol 15, No 3 (2019) Hypertension and Headache: the Effect of Antihypertensive Drugs Abstract  similar documents
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova
"... ; it is known that some angiotensin converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers ..."
 
Vol 13, No 4 (2017) CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE Abstract  similar documents
O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva
"... The features of the pharmacokinetics of the angiotensin II receptor blocker telmisartan ..."
 
Vol 10, No 6 (2014) CHANGES IN PREHOSPITAL PHARMACOTHERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN 2005-2014 ACCORDING TO THE LIS REGISTER Abstract  similar documents
S. Y. Martsevich, M. L. Ginzburg, N. P. Kutishenko, A. V. Zagrebelnyy, I. S. Balashov, L. G. Garkina
"... . The positive changes in the prescription of antiplatelet agents (13.5% in 2005 and 27.4% in 2014), statins (1 ..."
 
Vol 11, No 2 (2015) ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY Abstract  PDF (Eng)  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina
"... % of the patients received novel oral anticoagulants (dabigatran – 14%, rivaroxaban – 2%). Bleeding was fixed in 4 ..."
 
Vol 13, No 2 (2017) ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE Abstract  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya
"... conditions is studied well. The key role of aldosterone receptor blockers, particularly spironolactone ..."
 
Vol 15, No 4 (2019) Antihypertensive Drug Utilization in Two Districts of Northern Cyprus Abstract  PDF (Eng)  similar documents
M. Tamirci, R. Demirdamar
"... the antihypertensive drug choices and good prescribing principles. The prescribed antihypertensive agents were ..."
 
Vol 8, No 1 (2012) EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK Abstract  similar documents
I. M. Sokolov, N. A. Zheleznyakova
"... clinical trials. The triple combination of calcium antagonist, angiotensin II receptor blocker and thiazide ..."
 
Vol 3, No 1 (2007) EFFECTS OF SYMPATHOMIMETIC AGENTS ON ELECTROCARDIOGRAM INDEXES IN PATIENTS WITH BRONCHIAL ASTHMA Abstract  similar documents
I. G. Fomina, G. K. Makchnach, D. A. Zateyschikova, A. I. Tarzimanova
"... Aim. To study effects of sympathomimetic agents on electrocardiogram (ECG) indexes in patients ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... increased by 13% in the both genders. Men with IHD received antiplatelet agents more often than women. So ..."
 
Vol 9, No 4 (2013) VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... of nicotine addiction in adults and a small number of side events. Varenicline is the main agent ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... (warfarin), antiplatelet therapy (acetylsalicylic acid) and novel oral anticoagulants such as apixaban ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... K antagonists (such as warfarin), antiplatelet therapy (such as acetylsalicylic acid) and novel oral ..."
 
Vol 8, No 4 (2012) ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin
"... antiplatelet agents are considered. Besides the evidence base for the practical application of new antiplatelet ..."
 
Vol 6, No 3 (2010) THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova
"... Цель. Изучить взаимосвязь состояния ренин-ангиотензин-альдостероновой системы (РААС) с уровнем ..."
 
Vol 9, No 6 (2013) СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN Abstract  similar documents
I. I. Chukaeva, Ya. G. Spiryakina
"... properties of angiotensin receptor blocker losartan, so it can be used as first-line therapy in patients ..."
 
Vol 7, No 4 (2011) ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID Abstract  similar documents
I. N. Bokarev, L. V. Popova
"... is highlighted. ASA modes of action and its position among the modern antiplatelet agents are considered ..."
 
Vol 11, No 1 (2015) CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, S. V. Utkina
"... One of the three clinical examples of hospital thrombolysis using Russian thrombolytic agent ..."
 
Vol 15, No 2 (2019) Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction Abstract  similar documents
A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh
"... one year after STEMI and pharmacoinvasive reperfusion with fibrin-specific thrombolytic agents ..."
 
Vol 14, No 2 (2018) WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
M. Yu. Gilyarov, Е. V. Konstantinova
"... of thienopyridine P2Y12 receptor inhibitor prasugrel in the treatment of patients with acute coronary syndrome (ACS ..."
 
Vol 11, No 2 (2015) RESISTANT ARTERIAL HYPERTENSION: IS THE CONSENSUS BETWEEN CONSERVATIVE AND INTERVENTIONAL THERAPY POSSIBLE? Abstract  similar documents
Yu. I. Grinshtein, V. V. Shabalin
"... antihypertensive agents, one of which is a diuretic. The up-to-date approaches to optimal pharmacologic ..."
 
Vol 12, No 6 (2016) THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME Abstract  similar documents
E. A. Smirnova, S. S. Yakushin
"... (ACS). According to current recommendations three groups of agents are used as anticoagulants in ACS ..."
 
Vol 14, No 1 (2018) OUTPATIENT REGISTRY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (PROFILE-IM): DATA ON PREHOSPITAL THERAPY IN COMPARISON WITH THE LIS-3 REGISTRY Abstract  similar documents
N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov, S. Yu. Martsevich
"... enzyme inhibitors/angiotensin receptor blockers before AMI in patients from PROFILE-MI were prescribed ..."
 
Vol 4, No 1 (2008) ACUTE CEREBROVASCULAR EVENTS IN PATIENTS WITH ARTERIAL HYPERTENSION: MOLECULAR GENETIC ASPECTS Abstract  similar documents
M. A. Karpenko, E. G. Shatskaya, V. N. Solntsev, M. A. Bogdanov, V. I. Larionova
"... (ACE), angeotensin II type 1 receptor (ATR1), apolipoprotein СIII (APO CIII), apoproteine Е (APO E ..."
 
Vol 15, No 2 (2019) The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention Abstract  similar documents
A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov
"... and platelet P2Y12 receptor inhibitors. One of the first drugs from the group of P2Y12 receptor inhibitors ..."
 
Vol 14, No 3 (2018) COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU Abstract  similar documents
S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca
"... Aim. To study the structure of medical prescriptions of antihypertensive agents for patients ..."
 
Vol 6, No 4 (2010) LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... системы (РААС). Первыми лекарствами, блокирующими РААС, стали ингибиторы ангиотензинпревращающего фермента ..."
 
Vol 9, No 4 (2013) THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev
"... is discussed. Approaches to antiplatelet agent choice according to pharmacogenetic CYP2C19 testing, as well ..."
 
Vol 4, No 1 (2008) COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL) Abstract  similar documents
N. M. Chihladze, O. A. Sivakova, H. F. Samedova, G. N. Litonova, E. B. Yarovaya, I. E. Chazova
"... Aim. To compare antihypertensive efficacy of АТ1 receptors blocker (losartan) and ACE inhibitor ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... комбинированной терапии, включающей или не включающей блокаторы ренин-ангиотензин-альдостероновой системы (РААС ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
"... . The alternative antithrombotic agents, including rivaroxaban presented along with the traditional drugs (acetyl ..."
 
Vol 5, No 5 (2009) INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. V. Egorkina, V. M. Gorbunov, E. S. Abirova
"... and angiotensin receptor blockers are shown. Results of comparative studies on influence of combined therapy ..."
 
Vol 6, No 6 (2010) REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY" Abstract  similar documents
A. A. Aleksandrov
"... The classic hypoglycemic agents include biguanides, sulfonylurea drugs, meglitinides, glitazones ..."
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... receptor type 1 А1166С gene was carried out using a polymerase chain reaction (PCR) with evaluating ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. Eur J ..."
 
Vol 14, No 4 (2018) New Clinical Aspects of Eplerenone Use in Clinical Practice Abstract  similar documents
S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina
"... of mineralocorticoid receptor antagonists in patients with heart failure with reduced left ventricular ejection ..."
 
Vol 8, No 6 (2012) THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS Abstract  similar documents
S. Yu. Martsevich, M. L. Gynzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. U. Drozdova, E. V. Daniels, A. V. Fokina
"... reference AMI only a small number of the patients received the main drug groups (antiplatelet agents, β ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... .01, respectively). Patients treated with ACE inhibitors or angiotensin receptor blockers (ARB) had lower all-cause ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... prevention in AF patients are presented. Special attention paid to new agents for oral anticoagulation ..."
 
Vol 6, No 6 (2010) REALITIES AND PROSPECTS FOR PHARMACOLOGICAL CORRECTION OF «ADMA-ENOS"-ASSOCIATED WAYS IN PREECLAMPSIA Abstract  similar documents
M. V. Pokrovsky, N. G. Filipenko, M. V. Korokin, V. V. Gureyev, T. G. Pokrovsky, A. A. Barsuk, L. V. Korokina, E. V. Proskuryakova, N. V. Maltseva, O. V. Levashova, O. S. Gudyrev, A. S. Belous, O. S. Polyanskaya
"... agents have been effective in this model. Studies of endotelioprotective activity in other «ADMA-eNOS ..."
 
Vol 2, No 4 (2006) THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. V. Konstantinova, A. V. Magnitskyi, N. A. Schostak
"... and safety of fibrinolytics by their combination with acetylsalicylic acid, IIb/IIIa receptor inhibitors ..."
 
Vol 13, No 1 (2017) EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 Abstract  similar documents
L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin
"... статинов была 13,7%, блокаторов ренини-ангиотензин-альдостероновой системы (РААС) – 29 ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... Widespread use of antihypertensive and lipid-lowering agents in clinical practice determines ..."
 
Vol 12, No 4 (2016) Adherence to attendance at outpatient clinic, quality of prehospital therapy, and direct outcome of acute coronary syndrome: analysis within LIS-3 registry Abstract  similar documents
Yu. V. Semenova, N. P. Kutishenko, A. V. Zagebelnyy, A. D. Deev, M. L. Ginzburg, S. Yu. Martsevich
"... infarction as an outcome of ACS. Taking antiplatelet agents, beta-blockers and long-acting nitrates before ..."
 
Vol 7, No 1 (2011) TIMING OF PRE-OPERATIVE BETA-BLOCKER TREATMENT IN VASCULAR SURGERY PATIENTS: INFLUENCE ON POST-OPERATIVE OUTCOME  similar documents
W.-J. Flu, J.-P. van Kuijk, M. Chonchol, T. A. Winkel, H.J.M. Verhagen, J. J. Bax, D. Poldermans
"... , пероральных антикоагулянтов, ингиби- торов ренин-ангиотензин-альдостероновой системы (РААС) — ингибиторов ..."
 
1 - 100 of 671 Items 1 2 3 4 5 6 7 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)